ZNTL CIK: 1725160

Zentalis Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.45
FY23:
0.50
FY24:
0.39
FY25:
0.25
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.09
FY23:
0.05
FY24:
0.04
FY25:
0.04
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.54
FY23:
0.55
FY24:
0.43
FY25:
0.29

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.04
FY22:
0.06
FY23:
0.07
FY24:
0.05
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.05
FY23:
0.04
FY24:
0.04
FY25:
0.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.36
FY22:
0.43
FY23:
0.44
FY24:
0.34
FY25:
0.22
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.54
FY23:
0.55
FY24:
0.43
FY25:
0.29

All amounts in billions USD Data source:SEC EDGAR